Latest news
European Equities Mixed in Friday Trading; Novo Nordisk Says Ziltivekimab Fails to Reduce Major Adverse Cardiovascular Events in Trial - finance.yahoo.comfinance.yahoo.com · Fri, 31 Jul 2026 07:00:00 GMTNABP to Develop National Adverse Event Reporting Clearinghouse for Compounded Medications - finance.yahoo.comfinance.yahoo.com · Wed, 29 Jul 2026 07:00:00 GMT